Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]
, 2020 On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P. +4 more
core +2 more sources
Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition
International Journal of Infectious Diseases, 2020 • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is spreading globally. However, clinically effective antiviral treatments are not established.
Hidenori Takahashi +8 more
doaj +1 more source
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19) [PDF]
Clinical and Experimental Pediatrics, 2020 A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as ...
Su Eun Park
doaj +1 more source
Lung Transplantation for Adult Respiratory Distress Syndrome after SARS-CoV-2 Infection
The Thoracic & Cardiovascular Surgeon Reports, 2022 Background The majority of patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection present mild symptoms. However, some patients develop severe acute respiratory distress syndrome (ARDS) and subsequent irreversible lung ...
Achim Koch +6 more
doaj +1 more source
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission. [PDF]
, 2020 With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship,
Coil, David A +5 more
core +2 more sources
Molecular immune pathogenesis and diagnosis of COVID-19
Journal of Pharmaceutical Analysis, 2020 Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus ...
Xiaowei Li +4 more
doaj +1 more source
Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003 [PDF]
, 2004 During the 2003 severe acute respiratory syndrome (SARS) outbreak, a real-time quantitative polymerase chain reaction, which targets the nucleocapsid gene at the 3′-end of the viral genome, was established to detect and identify the SARS-associated ...
Briese, Thomas +17 more
core +3 more sources
Fatal spontaneous pneumomediastinum complicating SARS-COV2 pneumonia in a pregnant women
Journal of Obstetric Anaesthesia and Critical Care, 2023 Pneumomediastinum was reported as a complication of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pneumonia in the general population. Data concerning the association of this complication with pregnancy are rare.
Youssef Motiaa +3 more
doaj +1 more source
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. [PDF]
, 2020 An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses.
Cheng, Genhong +15 more
core
The SARS-coronavirus-host interactome [PDF]
, 2011 Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to ...
Brunn, Albrecht von +27 more
core +1 more source